Increased the required number of non-executive directors for the Northampton General Hospital NHS Trust from six to seven.

This Order modifies the governance structure of the Northampton General Hospital NHS Trust by increasing the number of non-executive directors.

It directs the trust to maintain a board consisting of a chairman, seven non-executive directors, and five executive directors.

The Order applies specifically to the Northampton General Hospital NHS Trust and its internal administrative composition.

Introduced mandatory three-year enhanced DBS checks for pharmacy staff and restricted pharmacists from dispensing prescriptions issued by their own employees.

These Regulations amend the 2013 framework governing pharmaceutical services in England to introduce new clinical governance standards and operational requirements for NHS pharmacists and Local Pharmaceutical Service (LPS) contractors.

The instrument restricts pharmacists from dispensing items prescribed by themselves or their employees unless specific 'best interests' criteria are met and forbids changing a patient's nominated dispensing contractor without explicit consent.

It also mandates three-yearly enhanced DBS checks for all professional staff and establishes a formal notification process for pharmacies to temporarily close for staff training without breaching their core opening hours obligations.

Added meningitis, tetanus, diphtheria, and polio vaccines to the list of medicines subject to zero or nominal NHS reimbursement in England starting 20 July 2026.

These regulations amend the National Health Service (Pharmaceutical and Local Pharmaceutical Services) Regulations 2013 to include several additional vaccines in the list of medicines eligible for zero or nominal reimbursement.

They apply to NHS pharmaceutical service providers in England who administer centrally purchased vaccines for meningococcal disease (groups A, C, W, Y, and B), tetanus, diphtheria, and polio.

The instrument ensures that where the government has already paid for the supply of these vaccines, pharmacies do not receive a standard purchase price reimbursement for them.

The Regulations updated the payment percentages within the statutory scheme governing costs associated with branded health service medicines for periods starting July 2026 and beyond.

These Regulations, made by the Secretary of State for Health and Social Care, amend the Branded Health Service Medicines (Costs) Regulations 2018, which establishes a scheme requiring manufacturers and suppliers of branded medicines for the National Health Service (NHS) to pay amounts based on net sales income; the amendments update specific payment percentages applicable for periods beginning July 1st, 2026, and for subsequent years across England, Wales, Scotland, and Northern Ireland.

The Regulations amended the 2015 rules to clarify charge exemptions for overseas visitors seeking specific NHS treatments and added Hantavirus disease to the Schedule 1 list of exempt conditions, applying retrospectively to May 1st, 2026.

These Regulations amend the 2015 rules governing National Health Service charges for overseas visitors in England by introducing and clarifying exemptions related to specific diseases and the circumstances under which visitors seek treatment.

Specifically, the amendment clarifies that charges must generally be applied if an overseas visitor came to the UK explicitly for the diagnosis or treatment of a condition listed in Schedule 1, unless the travel was state-approved or funded.

Furthermore, the Regulations add Hantavirus disease, including its severe forms, to the list of conditions exempt from visitor charges, ensuring treatment is free for overseas visitors, and mandates that charges made since May 1st, 2026, for this specific disease must not be recovered or must be repaid.

Amended NHS GP contracts to remove online consultation limits and mandate electronic registration and screening data sharing.

These Regulations amend the standard contracts for General Medical Services and Personal Medical Services in England to modify how patients interact with GP practices and pharmacies.

The instrument directs GP contractors to stop limiting online consultation requests during core hours, requires them to provide next-day responses for non-urgent matters, and mandates cooperation with the national Lung Cancer Screening Programme.

It applies to all NHS GP contractors and NHS England, establishing new duties for data sharing, staff survey participation, and the use of digital registration tools.

Dissolved the Cambridgeshire Community Services National Health Service Trust and revoked its 2010 establishment order.

This Order dissolves the Cambridgeshire Community Services National Health Service Trust on 1 April 2026 and revokes its original 2010 establishment order.

It applies to the administrative structure of the National Health Service in England, specifically terminating the legal existence of the named Trust.

NHS England issued this order following an application by the Trust and with the approval of the Secretary of State for Health and Social Care.

The Regulations mandated risk assessments, required public bodies to implement reasonable steps to address identified modern slavery risks in NHS procurements, and delegated guidance creation to NHS England.

These Regulations mandate that public bodies must assess the modern slavery risk associated with procuring goods or services for the health service in England, requiring them to take reasonable, proportionate steps to address or eliminate those risks during procurement design, contract management, and throughout the lifecycle of framework agreements and dynamic markets, with guidance to be issued by NHS England.